Profile
Jason Carlton worked as an Executive Director of Clinical Operations at Ultragenyx Pharmaceutical, Inc. and as the Head of Global Clinical Operations at Genentech, Inc. He also worked as a Vice President of Clinical Operations at Jasper Therapeutics, Inc. for a brief period in 2022.
Mr. Carlton completed his undergraduate degree at LaSalle University.
Former positions of Jason Carlton
| Companies | Position | End |
|---|---|---|
| JASPER THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2022-10-31 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
| ULTRAGENYX PHARMACEUTICAL INC. | Chief Tech/Sci/R&D Officer | - |
Training of Jason Carlton
| LaSalle University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| JASPER THERAPEUTICS, INC. | Finance |
| ULTRAGENYX PHARMACEUTICAL INC. | Health Technology |
| Private companies | 1 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Jason Carlton
